CMSC Abstracts View

Jiwon Oh, MD1, Ludwig Kappos, MD2, Giancarlo Comi, MD3, Mark S Freedman, MD4, Jerome de Seze, MD5, Jerry S Wolinsky, MD6, Philippe Truffinet, MD7, Myriam Benamor, MD7, Karthinathan Thangavelu, PhD8 and Aaron E Miller, MD9, (1)St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (5)University Hospital of Strasbourg, Strasbourg, France, (6)University of Texas Health Science Center at Houston, Houston, TX, (7)Sanofi Genzyme, Chilly-Mazarin, France, (8)Sanofi Genzyme, Cambridge, MA, (9)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY

John R Rinker II, MD, Neurology, Birmingham VA Medical Center, Birmingham, AL, Patrizia De Sarno, PhD, Neurology, University of Alabama at Birmingham, Birmingham, AL and Chander Raman, PhD, Medicine, University of Alabama at Birmingham, Birmingham, AL

Keith R Edwards, MD1, Stanley Cohan, MD, PhD2, Lore Garten, MD, Ph. D.1, James Thomas, M.D.3, Kyle E Smoot, MD2, Kiren Kresa-Reahl, MD2, Judy O’Connor, BSW, CCRC1, Tiffany Gervasi, Clinical Research Coordinator2, Chiayi Chen, Ph.D.2, Jessica Siuta, BSMT, ASCP, Clinical Research Coordinator1 and Vineetha Kamath, BS1, (1)MS Center of Northeastern New York, Latham, NY, (2)Providence Multiple Sclerosis Center, Portland, OR, (3)Radiology, Community Care Physicians, P.C., Latham, NY

Kendra L Yale, MMS, PA-C, MSCS1, Kristin Stockman, MSN, ANP-BC, MSCS1 and Shannon Cornell, MSN, ANP-BC, MSCS2, (1)Neurology, University of Colorado, Aurora, CO, (2)University of Colorado, Aurora, CO

Kiren Kresa-Reahl, MD1, Natalie C Edwards, MSc2, Gary Schneider, ScD3, Kevin Stern, BS3 and Amy L Phillips, PharmD4, (1)Providence MS Center, Portland, OR, (2)Health Services Consulting Corporation, Boxborough, MA, (3)Boston Health Economics, Inc., Waltham, MA, (4)EMD Serono, Inc., Rockland, MA

Kirstin Nygren, MSN, FNP-BC, MSCN and Barbara Giesser, MD, Neurology, UCLA, Los Angeles, CA

Laura J Balcer, MD, MSCE1, Steven Galetta, MD1, Jai Perumal, MD2, Roumen Balabanov, MD3, Robert J Fox, MD, FAAN4, Qunming Dong, MD5, Shavy Makh, MPhil5, Christophe Hotermans, MD5, John S Walsh, MD5, Denise Campagnolo, MD6 and Lily Lee, MD5, (1)New York University Langone Medical Center, New York, NY, (2)Judith Jaffe Multiple Sclerosis Center, New York, NY, (3)Rush University Multiple Sclerosis Center, Chicago, IL, (4)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Biogen, Cambridge, MA, (6)Formerly Biogen, Cambridge, MA

Lori Mayer, DNP, MSN, RN1, Ludwig Kappos, MD2, Michael K Racke, MD3, Kottil Rammohan, MD4, Anthony Traboulsee, MD5, Jerry Wolinsky, MD6, Cathy Chognot, PhD7, Laura Julian, PhD8, Julie Napieralski, PhD7, Johan van Beek, PhD7, Hanzhe Zheng, PhD8 and Stephen L Hauser, MD9, (1)Central Texas Neurology Consultants, Multiple Sclerosis Clinic of Central Texas, Round Rock, TX, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)Wexner Medical Center, Ohio State University, Columbus, OH, (4)University of Miami, Miami, FL, (5)University of British Columbia, Vancouver, BC, Canada, (6)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Genentech Inc., South San Francisco, CA, (9)University of California, San Francisco, San Francisco, CA

Louise M Rath, RN, MA (Bioethics), Neurosciences, Alfred Health, Melbourne, Australia

Malissa C Ayers, Physician Assistant, Mellen Center, Cleveland Clinic Foundation, Cleveland, OH and Mary A Willis, MD, Mellen Center, Cleveland Clinic, Cleveland, OH

Mehul Jhaveri, PharmD, MPH1, Ning Wu, PhD1, Crystal Watson, MS1, Kun Yang, PharmD2 and Daniel Jones, PhD2, (1)Biogen, Cambridge, MA, (2)Biogen, Weston, MA

Konstantin Balashov, MD1, Richard Macdonell, MD2, Kathryn Giles, MD, MSc, FRCPC3, Nicholas Everage, PhD4, Claudia Prada, MD, PhD4, Katherine Riester, MPH4, Dane Cloutier, MSc5 and Mihaela Vlaicu, MD5, (1)Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, (2)Austin Health, University of Melbourne, Melbourne, Australia, (3)Cambridge Memorial Hospital, Cambridge, ON, Canada, (4)Biogen, Cambridge, MA, (5)Biogen, Mississauga, ON, Canada

Mitzi J Williams, MD1, Lilyana Amezcua, MD, MS2, Alexander Green, MD, MPH3, Hollie Schmidt, MS4, Jia Zhou, MS5, Qiang Hou, PhD5, Jaanai Babb, PharmD6, Jessica Royall, MBA6 and Terrie Livingston, PharmD6, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Neurology, University of Southern California, Los Angeles, CA, (3)Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, (4)Accelerated Cure Project for MS, Waltham, MA, (5)Biogen, Cambridge, MA, (6)Biogen, Weston, MA

Nasima Afsari, MBBS, MPH, Neurology, Medstar Georgetown University Hospital, Washington DC, DC

Patricia K Coyle, MD1, Bhupendra Khatri, MD2, Keith R Edwards, MD3, Steve Cavalier, MD4, Pascal Rufi, MD5, Karthinathan Thangavelu, PhD4, Myriam Benamor, MD5 and Ralf Gold, MD6, (1)Stony Brook University, Stony Brook, NY, (2)The Regional MS Center, Center for Neurological Disorders at Wheaton Franciscan Healthcare, Milwaukee, WI, (3)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (4)Sanofi Genzyme, Cambridge, MA, (5)Sanofi Genzyme, Chilly-Mazarin, France, (6)St Josef Hospital, Ruhr University Bochum, Bochum, Germany

Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN, Neurology Associates, PA, Maitland, FL, Christopher LaGanke, MD, North Central Neurology Associates, Cullman, AL and Constance B Easterling, RN, MSN, ANP, MSCN, Multiple Sclerosis Care Center of Neurological Services, Hackensack, NJ

Paul Ford, Ph.D.1, Stacey S Cofield, PhD2, Tuula Tyry, PhD3, Carol Cosenza, MSW4, Amber Salter, PhD5, Mary Beth Mercer, MPH1, Sneha Natarajan, PhD6, Lauren Cripps, MA4, Gary Cutter, PhD7 and Robert J Fox, MD, FAAN6, (1)Bioethics, Cleveland Clinic, Cleveland, OH, (2)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (3)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (4)Center for Survey Research, University of Massachusetts, Boston, Boston, MA, (5)Biostatistics, Washington University in St. Louis, St. Louis, MO, (6)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (7)University of Alabama at Birmingham, Birmingham, AL

Aaron Boster, MD1, Pavle Repovic, MD, PhD2, Shannon Ritter, MS3, Davorka Tomic, PhD4, Xiangyi Meng, PhD3, Daniela P Meier, MD4, Fernanda Boulos, MD3, Frederik Barkhof, MD, PhD5 and Till Sprenger, MD6, (1)Ohio State University, Columbus, OH, (2)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Novartis Pharma AG, Basel, Switzerland, (5)Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands, (6)Medical Image Analysis Center and Department of Neurology, University Hospital Basel, Basel, Switzerland

Aaron Boster, MD1, Pavle Repovic, MD, PhD2, Xiangyi Meng, PhD3, Daniela P Meier, MD4, Fernanda Boulos, MD3, Till Sprenger, MD5 and Frederik Barkhof, MD, PhD6, (1)Ohio State University, Columbus, OH, (2)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Novartis Pharma AG, Basel, Switzerland, (5)Medical Image Analysis Center and Department of Neurology, University Hospital Basel, Basel, Switzerland, (6)Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands

Ralph HB Benedict, PhD1, Douglas L Arnold, MD2,3, Bruce AC Cree, MD4, Xiangyi Meng, PhD5, Lesley Schofield, PhD5, Fernanda Boulos, MD5 and Nadia Tenenbaum, MD5, (1)University at Buffalo, State University of New York, Buffalo, NY, (2)NeuroRx Research, Montreal, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)Multiple Sclerosis Center, San Francisco, CA, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Regina Berkovich, MD1, Hao Zhang, PhD2, Julie Aldridge, MS2, Scott Baver, PhD3 and Eric Williamson, MD4, (1)University of Southern California, Los Angeles, CA, (2)EMD Serono, Inc., Billerica, MA, (3)EMD Serono, Inc., Rockland, MA, (4)University of Pennsylvania Penn Neuroscience Center, Philadelphia, PA

Richard Macdonell, MD1, Mark S Freedman, MD2, Xianhao Xu, MD3, Steve Vucic, MD4, Philippe Truffinet, MD5, Myriam Benamor, MD5, Karthinathan Thangavelu, PhD6 and Aaron E Miller, MD7, (1)Austin Health, Heidelberg, Australia, (2)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (3)Beijing Hospital, Beijing, China, (4)University of Sydney, Sydney, Australia, (5)Sanofi Genzyme, Chilly-Mazarin, France, (6)Sanofi Genzyme, Cambridge, MA, (7)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY

Robert T Naismith, MD1, Richard A Leigh-Pemberton, MD2, Amy E Claxton, PhD2, Marjie L Hard, Ph.D.2, Yangchun Du, PhD2, Lisa von Moltke, MD2, Anthony J Lembo, MD3 and Jerry Wolinsky, MD4, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Alkermes, Inc., Waltham, MA, (3)Beth Israel Deaconess Medical Center, Boston, MA, (4)University of Texas Health Science Center at Houston, Houston, TX

Robert Zivadinov, MD1, Michael G Dwyer, PhD1, Ellen Carl, PhD1, Karthinathan Thangavelu, PhD2, Steve Cavalier, MD2 and Niels Bergsland, PhD1, (1)University at Buffalo, Buffalo, NY, (2)Sanofi Genzyme, Cambridge, MA

Salvatore Q Napoli, MD and Sarah B Cardoso, Research Coordinator, Neurology Center of New England P.C., Foxboro, MA

Samuel F Hunter, MD, PhD1, David H Margolin, MD, PhD2, Kastytis Sestakauskas, MD3, James Thomas, MD2, Claudio E Rodriguez, MD2, Vladimir Evilevitch, MD2 and Alan K Jacobs, MD2, (1)Advanced Neurosciences Institute, Franklin, TN, (2)Sanofi Genzyme, Cambridge, MA, (3)Sanofi Research & Development, Chilly-Mazarin, France

Santrina Fletcher, RN, MSN, CNP1, Rhonda Cortright, MSCS1, Mary Pat Bartoszek, CNP, MSCN2 and Colleen E Miller, DNS2, (1)Riverhills Neuroscience, Cincinnati, OH, (2)Sanofi Genzyme, Cambridge, MA

Sara Razmjou, MD, M.Sc, Maziar Eslami Farsani, MD, Sheridan Reed, BS, Samuel Lichtman-Mikol, BA, Navid Seraji-Bozorgzad, MD, M.Sc and Evanthia Bernitsas, MD, Neurology, Wayne State School of Medicine, Detroit, MI

Sibyl Wray, MD1, Silvia Bader-Weder, MD2, Regine Buffels, MD2, Donna Masterman, MD, MS3, Julie Napieralski, PhD2 and Stephen L Hauser, MD4, (1)Hope Neurology MS Center, Knoxville, TN, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)Genentech Inc., South San Francisco, CA, (4)University of California, San Francisco, San Francisco, CA

Stuart Cook, MD1, Thomas Leist, MD2, Giancarlo Comi, MD3, Xavier Montalban, MD4, Elke Sylvester, MD5, Christine Hicking, MS5 and Fernando Dangond, MD6, (1)Rutgers, The State University of New Jersey, Newark, NJ, (2)Thomas Jefferson University, Philadelphia, PA, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Hospital Universitari Vall d’Hebron, Barcelona, Spain, (5)Merck KGaA, Darmstadt, Germany, (6)EMD Serono, Inc., Billerica, MA

Stuart Cook, MD1, Thomas Leist, MD2, Giancarlo Comi, MD3, Xavier Montalban, MD4, Elke Sylvester, MD5, Christine Hicking, MS5 and Fernando Dangond, MD6, (1)Rutgers, The State University of New Jersey, Newark, NJ, (2)Thomas Jefferson University, Philadelphia, PA, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Hospital Universitari Vall d’Hebron, Barcelona, Spain, (5)Merck KGaA, Darmstadt, Germany, (6)EMD Serono, Inc., Billerica, MA

Thomas Finnegan, PhD, Medscape LLC, New York, NY, Gena Dolson, MS, Medscape Education, New York, NY and Stephen Krieger, MD, Icahn School of Medicine, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY

Thomas Leist, MD1, Giancarlo Comi, MD2, Mark S Freedman, MD3, Bruce AC Cree, MD4, Patricia K Coyle, MD5, Hans-Peter Hartung, MD6, Patrick Vermersch, MD7, Elke Sylvester, MD8, Doris Damian, PhD9 and Fernando Dangond, MD9, (1)Thomas Jefferson University, Philadelphia, PA, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (4)Multiple Sclerosis Center, San Francisco, CA, (5)Stony Brook University, Stony Brook, NY, (6)Heinrich Heine University, Dusseldorf, Germany, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)Merck KGaA, Darmstadt, Germany, (9)EMD Serono, Inc., Billerica, MA

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Guillermo G Garcia, BS3, Astrid Diaz, BS3, Ana Rivera, BS3 and Natalia Hernandez, BS3, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Guillermo G Garcia, BS3, Astrid Diaz, BS3, Natalia Hernandez, BS3 and Ana Rivera, BS3, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR

Brenda Young, BS1, Emmanuelle Waubant, MD, PhD2, Sabeen Lulu, MD2 and Jennifer Graves, MD, PhD, MAS3, (1)San Francisco, CA, (2)UCSF Pediatric MS Center, San Francisco, CA, (3)University of California, San Francisco, San Francisco, CA

Christine Nelson, PharmD, RPh, Kerry McCarthy, BSN, Shawn Burke, PharmD, RPh, Peishan Liu Snyder, PhD and Sarah Buckley, BSN, Biogen, Cambridge, MA

Alden R. Smith, PharmD1, Lobat Hashemi, ScD1, Frank Ragone, PhD1 and Deborah A Taira, ScD2, (1)Sanofi Genzyme, Cambridge, MA, (2)University of Hawaii, Hilo, HI